Zoetis shares slide 5.13% and underperform market and rivals
Updated
Updated · MarketWatch · May 8
Zoetis shares slide 5.13% and underperform market and rivals
10 articles · Updated · MarketWatch · May 8
The stock closed at $82.83 on Friday, its sixth straight loss, as the S&P 500 rose 0.84% and the Dow Jones Industrial Average edged up 0.02%.
Zoetis finished 51.91% below its 52-week high of $172.23 reached on 3 June, while Merck fell 0.82% and IDEXX Laboratories dropped 2.11%.
Trading volume reached 17.2 million shares, far above its 50-day average of 4.3 million, signalling unusually heavy selling despite a broadly positive market session.
After its worst week in years, is market leader Zoetis a historic bargain or a value trap for investors?
Can Zoetis's new plan revive its core U.S. business before generic rivals permanently erode its market share?
With vet care inflation soaring, is the 'fur baby' spending boom finally meeting its breaking point?